SYBLEU

SYBLEU P/TBV

The Price to Tangible Book Value (P/TBV) of SYBLEU (SYBE) as of Nov 4, 2026 is -8.40. In the previous year, Price to Tangible Book Value (P/TBV) was -21.88 — a change of -61.60% (higher).

P/TBV

-8.40

YoY

-61.60%

Last updated:

Price to Tangible Book Value (P/TBV) of SYBLEU is 2023 -8.40 . Price to Tangible Book Value (P/TBV) of SYBLEU was 2022 -21.88 . It decreases by -61.60% higher compared to the previous year.

The SYBLEU P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2020
-1,953.57 USD
Jan 1, 2021
-1,189.13 USD
Jan 1, 2022
-21.88 USD
Jan 1, 2023
-8.40 USD
The SYBLEU P/TBV history
YEARP/TBVYoY
-8.40-61.60%
-21.88-98.16%
-1,189.13-39.13%
-1,953.57—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SYBLEU Stock analysis

What does SYBLEU do? SYBLEU Inc develops regenerative medical applications focused on therapies for human and animal health, medical devices, and clinical diagnostics. The company generates revenue through the sale or licensing of its developed applications after completing Phase I or Phase II clinical trials, or by advancing them to Phase III trials. It also develops disposable medical devices and explores artificial intelligence and machine learning applications in clinical diagnostics. SYBLEU Inc targets the healthcare sector with its innovative medical solutions. The firm's primary products include therapies for human and animal health, medical devices, and clinical diagnostics. It also develops drugs for treating cancer in companion animals, leveraging artificial intelligence and machine learning in its diagnostic processes. SYBLEU Inc's business model relies on advancing its applications through clinical trials to either secure licensing deals or commercialize its products directly. SYBLEU Inc's target market segments are healthcare providers, veterinary clinics, and medical device manufacturers seeking innovative regenerative therapies and diagnostic tools. The company's focus on companion animal cancer treatments and AI-enhanced diagnostics positions it within specialized segments of the medical industry. Its development of disposable medical devices further expands its reach into the broader healthcare market. SYBLEU is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SYBLEU stock

Price to Tangible Book Value (P/TBV) of SYBLEU is -8.40 in 2023.

Price to Tangible Book Value (P/TBV) of SYBLEU changed from -21.88 to -8.40, representing a -61.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) SYBLEU since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s SYBLEU with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SYBLEU

All Key Metrics — SYBLEU